Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SensiFAST(TM) Genotyping Kit Exceed the Limit

Published: Thursday, November 29, 2012
Last Updated: Thursday, November 29, 2012
Bookmark and Share
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., announced the worldwide release of SensiFAST Genotyping Kit.

Bioline's SensiFAST Genotyping Kit has been developed for fast, precise, and highly reproducible genotyping of sequence variants, including loci with type IV SNPs. With outstanding allele clustering, the SensiFAST Genotyping Kit gives exceptional confidence in genotype calling with probe-based real-time PCR SNP detection applications. The kit has been validated on all commonly used instruments and features fast protocol times, making it ideal for high-throughput workflows.

Marco Calzavara, President of Bioline commented, "I am delighted to announce the release of another new research tool as part of the SensiFAST family, our rapidly expanding real-time PCR range. Bioline is dedicated to increasing the applications of our industry-leading real-time PCR portfolio tools. The SensiFAST Genotyping Kit will enable researchers to cost-effectively scan DNA from a variety of biological samples to detect the smallest genetic variations among samples."

Richard L. Eberly, President of Meridian Life Science, Inc., stated, "The release of the SensiFAST Genotyping Kit is part of a new generation of products to advance the rapidly expanding portfolio of highly specialized molecular biology reagents from Bioline. We remain committed to our life science customers to bring innovation and quality products to the research lab, clinical diagnostic laboratories, and biotechnology companies."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
New Genetic Risk Factors for Myopia Discovered
Genes and environment determine short-sightedness.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!